GRIA4 and Abnormality of the skin: In summary, this study provides evidence that GluA4-containing AMPARs are expressed in epidermal keratinocytes that human dermatopathies show alterations in the keratinocyte expression levels of GluA4-containing AMPAR, and that algogenic substances can directly regulate the production of GluA4 in keratinocytes.